Off-topic for aiqbench
This story was gathered from a source we follow but falls outside AI and quantum coverage, so there is no aiqbench take for it.
Talazoparib plus enzalutamide in high-volume metastatic hormone-naive prostate cancer: a randomized phase 2 trial
Nature1 min read
Talazoparib plus enzalutamide in high-volume metastatic hormone-naive prostate cancer: a randomized phase 2 trial Nature
Read the full article at NatureRelated coverage
AI Products
Game Design Creativity evals
LessWrong · Oct 12, 2026
Quantum Comms
Lattice-Based Cryptography Explained
Quantum Zeitgeist · Aug 15, 2026
AI Products
Biomedical Imaging's Real Bottleneck Is the Data, Not the Model
Databricks · Oct 8, 2026
AI Products
Tiered KV cache for large LLMs on Amazon SageMaker HyperPod with Curvine
AWS · Aug 12, 2026